Yuki Tsuji Selected Research

Yuki Tsuji Research Topics

Disease

22	Fibrosis (Cirrhosis) 01/2024 - 11/2017
14	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 11/2018
10	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2018
6	Sarcopenia 12/2023 - 09/2021
6	Fatty Liver 12/2023 - 10/2019
5	Liver Diseases (Liver Disease) 12/2023 - 06/2021
4	Non-alcoholic Fatty Liver Disease 11/2021 - 11/2017
3	Neoplasms (Cancer) 04/2024 - 10/2019
3	Thrombophilia 02/2024 - 12/2020
3	Atrophy 12/2023 - 08/2022
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 06/2023 - 07/2021
2	Thrombosis (Thrombus) 02/2024 - 09/2020
2	Inflammation (Inflammations) 12/2023 - 12/2022
2	Chronic Hepatitis (Chronic Active Hepatitis) 10/2023 - 11/2018
2	Chronic Hepatitis B 10/2023 - 08/2020
2	Ascites 05/2023 - 05/2022
2	Heart Failure 04/2023 - 07/2013
2	Acute-On-Chronic Liver Failure 01/2023 - 05/2020
2	Hyperammonemia 08/2022 - 03/2020
2	Dysbiosis 06/2021 - 01/2019
2	Cognitive Dysfunction 06/2021 - 03/2020
2	Infections 06/2021 - 09/2018
2	Thrombocytopenia (Thrombopenia) 09/2020 - 01/2020
2	Hepatic Encephalopathy 08/2020 - 03/2020
2	Insulin Resistance 08/2020 - 04/2008
1	COVID-19 04/2025
1	Cholangitis 04/2025
1	Choledocholithiasis 04/2025
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2025
1	Acute Kidney Injury (Acute Renal Failure) 01/2024
1	Vitamin D Deficiency 12/2023
1	Hypertension (High Blood Pressure) 10/2023
1	Dyslipidemias (Dyslipidemia) 10/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Starvation 10/2023

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2018
10	EndotoxinsIBA 12/2023 - 02/2019
7	von Willebrand FactorIBA 02/2024 - 11/2018
4	LipopolysaccharidesIBA 12/2023 - 06/2020
4	Amino Acids FDA Link 10/2023 - 03/2020
4	Rifaximin (L 105)FDA Link 10/2022 - 03/2020
3	Choline (Choline Chloride)IBA 12/2023 - 03/2020
3	AntigensIBA 01/2023 - 12/2020
3	Toll-Like Receptor 4IBA 10/2022 - 06/2021
3	CytokinesIBA 08/2022 - 03/2020
3	Angiotensin II Type 1 Receptor BlockersIBA 01/2022 - 11/2017
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2021 - 08/2020
3	Carrier Proteins (Binding Protein)IBA 10/2021 - 08/2020
3	Tissue Inhibitor of MetalloproteinasesIBA 10/2021 - 08/2020
3	Hyaluronic Acid (Hyaluronan)IBA 10/2021 - 08/2020
2	AnticoagulantsIBA 04/2025 - 09/2020
2	lenvatinibIBA 04/2024 - 10/2022
2	Losartan (Cozaar)FDA LinkGeneric 12/2023 - 01/2022
2	Angiotensin Receptor AntagonistsIBA 12/2023 - 08/2020
2	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2023 - 04/2023
2	Tight Junction ProteinsIBA 12/2023 - 08/2020
2	Hemoglobins (Hemoglobin)IBA 08/2023 - 06/2023
2	InterferonsIBA 10/2022 - 09/2018
2	AlbuminsIBA 10/2022 - 10/2021
2	BilirubinIBA 10/2022 - 10/2021
2	MyostatinIBA 08/2022 - 03/2022
2	ZincIBA 03/2022 - 09/2021
2	AmmoniaIBA 03/2022 - 03/2020
2	Collagen Type III (Type III Collagen)IBA 10/2021 - 08/2020
2	CollagenIBA 10/2020 - 08/2020
2	procollagen Type III-N-terminal peptide (PIIP)IBA 10/2020 - 08/2020
2	lusutrombopagIBA 09/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2020 - 03/2020
2	Bile Acids and Salts (Bile Acids)IBA 06/2020 - 11/2017
1	Ethiodized Oil (Ethiodol)FDA Link 04/2024
1	Metalloproteases (Metalloproteinases)IBA 02/2024
1	DisintegrinsIBA 02/2024
1	EnzymesIBA 02/2024
1	ThrombospondinsIBA 02/2024
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	Insulin-Like PeptidesIBA 12/2023
1	Angiotensin IIIBA 12/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2023
1	Methionine (L-Methionine)FDA Link 12/2023
1	Sirolimus (Rapamycin)FDA Link 12/2023
1	Claudin-2IBA 12/2023
1	hydroxide ionIBA 12/2023
1	Vitamin D FDA LinkGeneric 12/2023
1	Ethanol (Ethyl Alcohol)IBA 12/2023
1	OccludinIBA 12/2023
1	entecavir FDA Link 10/2023
1	tenofovir alafenamideIBA 10/2023
1	FumaratesIBA 10/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2023
1	semaglutideIBA 10/2023
1	TOR Serine-Threonine KinasesIBA 10/2023
1	Factor VII (Proconvertin)IBA 05/2023
1	Antithrombin IIIIBA 05/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 04/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2023
1	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2023
1	Messenger RNA (mRNA)IBA 04/2023

Therapy/Procedure

6	Therapeutics 05/2023 - 02/2019
1	Length of Stay 04/2025
1	Aftercare (After-Treatment) 10/2023